Page 56 - JCBP-3-1
P. 56
Journal of Clinical and
Basic Psychosomatics Psychosomatic influences on insomnia
117. De la Herrán-Arita AK, Equihua-Benítez AC, Drucker- doi: 10.3389/fpsyg.2019.02466
Colín R. Treatment of cataplexy. Expert Opin Orphan Drugs. 128. Rodrigues da Silva N, Gomes FV, Sonego AB, da Silva NR,
2013;1(3):199-210.
Guimarães FS. Cannabidiol attenuates behavioral changes in
doi: 10.1517/21678707.2013.765359 a rodent model of schizophrenia through 5-HT1A, but not
CB and CB receptors. Pharmacol Res. 2020;156:104749.
118. Equihua AC, De La Herrán-Arita AK, Drucker-Colin R. 1 2
Orexin receptor antagonists as therapeutic agents for doi: 10.1016/j.phrs.2020.104749
insomnia. Front Pharmacol. 2013;4:163.
129. Hablitz LM, Gunesch AN, Cravetchi O, Moldavan M,
doi: 10.3389/fphar.2013.00163 Allen CN. Cannabinoid Signaling recruits astrocytes to
modulate presynaptic function in the suprachiasmatic
119. De la Herrán-Arita AK, Equihua-Benítez AC,
Drucker-Colín R. Orexin/hypocretin antagonists in nucleus. eNeuro. 2020;7(1).
insomnia: From bench to clinic. In: Milestones in Drug doi: 10.1523/eneuro.0081-19.2020
Therapy. Cham: Springer; 2014. p. 191-207.
130. Torres-Mondragón LE, León-Pimentel LC, Pérez-
doi: 10.1007/978-3-319-11514-6_9 Tamayo DE, De la Herrán-Arita AK. The endocannabinoid
system: A new frontier in addressing psychosomatic
120. De la Herrán-Arita AK, García-García F. Current and
emerging options for the drug treatment of narcolepsy. challenges. J Clin Basic Psychosom. 2024;2(1):2288.
Drugs. 2013;73(16):1771-1781. doi: 10.36922/jcbp.2288
doi: 10.1007/s40265-013-0127-y 131. Ried K, Tamanna T, Matthews S, Sali A. Medicinal cannabis
improves sleep in adults with insomnia: A randomised
121. Osuna-Ramos JF, Camberos-Barraza J,
Torres-Mondragón LE, et al. Interplay between the double-blind placebo-controlled crossover study. J Sleep Res.
glymphatic system and the endocannabinoid system: 2023;32(3):e13793.
Implications for brain health and disease. Int J Mol Sci. doi: 10.1111/jsr.13793
2023;24(24):17458-17458.
132. Xantus G, Zavori L, Matheson C, Gyarmathy VA,
doi: 10.3390/ijms242417458 Fazekas LM, Kanizsai P. Cannabidiol in low back pain:
Scientific rationale for clinical trials in low back pain. Expert
122. Pérez-Morales M, De La Herrán-Arita AK, Méndez-Díaz M,
Ruiz-Contreras AE, Drucker-Colín R, Prospéro-García O. Rev Clin Pharmacol. 2021;14(6):671-675.
2-AG into the lateral hypothalamus increases REM sleep doi: 10.1080/17512433.2021.1917379
and cFos expression in melanin concentrating hormone 133. Namdar D, Koltai H. Medical cannabis for the treatment of
neurons in rats. Pharmacol Biochem Behav. 2013;108:1-7.
inflammation. Nat Prod Commun. 2018;13(3):249-254.
doi: 10.1016/j.pbb.2013.04.006
doi: 10.1177/1934578x1801300304
123. Zou S, Kumar U. Cannabinoid receptors and the 134. Bruni O, Ferini-Strambi L, Giacomoni E, Pellegrino P.
endocannabinoid system: Signaling and function in the Herbal remedies and their possible effect on the GABAergic
central nervous system. Int J Mol Sci. 2018;19(3):833.
system and sleep. Nutrients. 2021;13(2):530.
doi: 10.3390/ijms19030833
doi: 10.3390/nu13020530
124. Low ZXB, Lee XR, Soga T, Goh BH, Alex D, Kumari Y. 135. Zeng H, Xu J, Zheng L, et al. Traditional Chinese herbal
Cannabinoids: Emerging sleep modulator. Biomed formulas modulate gut microbiome and improve insomnia
Pharmacother. 2023;165:115102.
in patients with distinct syndrome types: Insights from an
doi: 10.1016/j.biopha.2023.115102 interventional clinical study. Front Cell Infect Microbiol.
2024;14:1395267.
125. Mechoulam R, Gaoni Y. A total synthesis of dl-delta-1-
tetrahydrocannabinol, the active constituent of hashish. doi: 10.3389/fcimb.2024.1395267
J Am Chem Soc. 1965;87:3273-3275.
136. Deuel LM, Seeberger LC. Complementary therapies
doi: 10.1021/ja01092a065 in parkinson disease: A review of acupuncture, Tai
Chi, Qi Gong, Yoga, and Cannabis. Neurotherapeutics.
126. Glodosky NC, Cuttler C, McLaughlin RJ. A review of the
effects of acute and chronic cannabinoid exposure on the 2020;17(4):1434-1455.
stress response. Front Neuroendocrinol. 2021;63:100945. doi: 10.1007/s13311-020-00900-y
doi: 10.1016/j.yfrne.2021.100945 137. Li H, Chen J, Xu G, et al. The effect of Tai Chi for improving
sleep quality: A systematic review and meta-analysis. J Affect
127. Masataka N. Anxiolytic effects of repeated cannabidiol
treatment in teenagers with social anxiety disorders. Front Disord. 2020;274:1102-1112.
Psychol. 2019;10:2466. doi: 10.1016/j.jad.2020.05.076
Volume 3 Issue 1 (2025) 50 doi: 10.36922/jcbp.4588

